129 related articles for article (PubMed ID: 2564709)
1. [Possible causes for an increased content of blood peptide hormones in small-cell lung cancer].
Raĭkhlin NT; Smirnova EA; Blinova SA; Deĭneko GM; Bassalyk LS
Vopr Onkol; 1989; 35(2):203-7. PubMed ID: 2564709
[TBL] [Abstract][Full Text] [Related]
2. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
[TBL] [Abstract][Full Text] [Related]
3. Tissue polypeptide antigen in bronchogenic carcinoma.
Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O
Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159
[TBL] [Abstract][Full Text] [Related]
4. [The dynamics of the hormonal and tumor marker levels in response to adrenaline administration in lung cancer patients].
Khudoleĭ VN; Velichko SA
Vopr Onkol; 1992; 38(10):1209-17. PubMed ID: 1343147
[TBL] [Abstract][Full Text] [Related]
5. Association of serum reactive oxygen metabolite levels with different histopathological types of lung cancer.
Gencer M; Ceylan E; Aksoy N; Uzun K
Respiration; 2006; 73(4):520-4. PubMed ID: 16432293
[TBL] [Abstract][Full Text] [Related]
6. Serum tumour markers in lung cancer.
Hansen M
Scand J Clin Lab Invest Suppl; 1991; 206():93-101. PubMed ID: 1658919
[No Abstract] [Full Text] [Related]
7. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
Stieber P; Dienemann H; Schalhorn A; Schmitt UM; Reinmiedl J; Hofmann K; Yamaguchi K
Anticancer Res; 1999; 19(4A):2673-8. PubMed ID: 10470218
[TBL] [Abstract][Full Text] [Related]
8. [Clinical usefulness of a new tumor marker CYFRA21-1 in patients with lung cancer].
Li R; Li R; Wang Y
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):26-9. PubMed ID: 11263296
[TBL] [Abstract][Full Text] [Related]
9. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite alterations in bronchial and sputum specimens of lung cancer patients.
Miozzo M; Sozzi G; Musso K; Pilotti S; Incarbone M; Pastorino U; Pierotti MA
Cancer Res; 1996 May; 56(10):2285-8. PubMed ID: 8625300
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine cells and neuroendocrine neoplasms of the lung.
Gould VE; Linnoila RI; Memoli VA; Warren WH
Pathol Annu; 1983; 18 Pt 1():287-330. PubMed ID: 6136018
[No Abstract] [Full Text] [Related]
12. Serum retinoic acid, retinol and retinyl palmitate levels in patients with lung cancer.
Moulas AN; Gerogianni IC; Papadopoulos D; Gourgoulianis KI
Respirology; 2006 Mar; 11(2):169-74. PubMed ID: 16548902
[TBL] [Abstract][Full Text] [Related]
13. Elastin metabolism parameters in sera of patients with lung cancer.
Gmiński J; Mykala-Cieśla J; Machalski M; Drózdz M
Neoplasma; 1993; 40(1):41-4. PubMed ID: 8394514
[TBL] [Abstract][Full Text] [Related]
14. Pro-gastrin-releasing peptide (Pro-GRP), a tumor marker for small cell lung cancer.
Oremek GM; Sapoutzis N
Anticancer Res; 2003; 23(2A):895-8. PubMed ID: 12820319
[TBL] [Abstract][Full Text] [Related]
15. [Bronchial cancer: new cell biology knowledge with relevance for diagnosis and therapy. A short review].
Heinemann V; Jehn U
Internist (Berl); 1985 Aug; 26(8):521-2. PubMed ID: 2865229
[No Abstract] [Full Text] [Related]
16. Evaluation of CYFRA 21-1 in malignant and benign pleural effusions.
Toumbis M; Rasidakis A; Passalidou E; Kalomenidis J; Alchanatis M; Orphanidou D; Jordanoglou J
Anticancer Res; 1996; 16(4A):2101-4. PubMed ID: 8712750
[TBL] [Abstract][Full Text] [Related]
17. [Pathomorphologic and endoscopic analysis of large bronchi during lung cancer].
Nepomniashchikh LM; Levitskiĭ VA; Nepomniashchikh GI; Aĭdagulova SV; Belov IIu; Naumova LA
Biull Eksp Biol Med; 2000 Mar; 129(3):347-51. PubMed ID: 10776584
[No Abstract] [Full Text] [Related]
18. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
[TBL] [Abstract][Full Text] [Related]
19. [Content of endocrine cells of the APUD-system of the lungs in cancer of that organ].
Blinova SA
Arkh Patol; 1988; 50(9):46-50. PubMed ID: 2904803
[TBL] [Abstract][Full Text] [Related]
20. Plasma 7beta-hydroxycholesterol as a possible predictor of lung cancer risk.
Linseisen J; Wolfram G; Miller AB
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1630-7. PubMed ID: 12496054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
